Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-826-9 | CAS number: 100-18-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Remarks:
- in vivo study that was performed prior to current requirement for in vitro alternative testing
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26 January 1982 - 16 April 1984
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26 January 1982 - 16 April 1984
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Specific details on test material used for the study:
- TEST MATERIAL
- name as cited in test report: p-diisopropylbenzene
- Molecular weight: 162 g/mol
- Molecular formula: C12H18
- Physical state: liquid
- Boiling point: 208°C at 760 mmHg
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: not specified
- Stability with H+; OH-; Heat, Light, H2: given - Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Remarks:
- 100 % as received
- Doses:
- 3200 mg/kg
- Control animals:
- no
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 3 200 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortalities were observed.
- Clinical signs:
- other:
- Gross pathology:
- No necropsies were conducted
- Interpretation of results:
- other: EU GHS criteria not met
- Conclusions:
- Based on the results of this study, the acute oral LD50 for test item was greater than 3200 mg/kg in male and female rats. Clinical signs of toxicity included slight to moderate weakness and rough coats.
- Executive summary:
An acute oral toxicity study was conducted on rats. Based on the results of this study, the acute oral LD50 for test item was greater than 3200 mg/kg in male and female rats. Clinical signs of toxicity included slight to moderate weakness and rough coats.
The acute oral LD50 of this compound was greater than 3200 mg/kg in male and female rats. Clinical signs of toxicity included slight to moderat weakness and rough coats.
- Reason / purpose for cross-reference:
- reference to same study
Reference
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26 January 1982 - 16 April 1984
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The test was conducted according to an internal method.
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- TEST MATERIAL
- name as cited in test report: p-diisopropylbenzene
- Molecular weight: 162 g/mol
- Molecular formula: C12H18
- Physical state: liquid
- Boiling point: 208 °C at 760 mmHg
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: not specified
- Stability with H+; OH-; Heat, Light, H2: given - Species:
- guinea pig
- Strain:
- not specified
- Sex:
- not specified
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- occluded, single exposure, 24 hours
(guinea pig abdomen) - Duration of exposure:
- 24 hours
- Doses:
- single dose (dose up to 20 mL/kg)
- Control animals:
- no
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 20 mL/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: = ca. 20000 mg/kg bw/d
- Clinical signs:
- other: erythema, edema, necrosis, eschars, scarring, desquamation and aloepcia
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based upon the results of this test, the acute dermal LD50 of test item was determined to be greater than 20 mL/kg bw (= ca. 20000 mg/kg bw/d).
- Executive summary:
The acute toxicity to guinea pig in dermal test was performed. At most, test item is only slightly toxic by the dermal route. There was no evidence of percutaneous absorption. LD50 value was determined to be greater than 20mL/kg bw (= ca. 20000 mg/kg bw/d).
It produced moderate to severe erythema and edema and some necrosis initially; eschars were present after one week, and scarring, desquamation and alopecia were present after two weeks at doses ranging from 20 mL/g down to 1 mL/kg.
The dermal LD50 was greater than 20 mL/kg.
- Reason / purpose for cross-reference:
- reference to same study
Reference
- Endpoint:
- skin irritation: in vivo
- Remarks:
- in vivo study that was performed prior to current requirement for in vitro alternative testing
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26 January 1982 - 16 April 1984
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The test was conducted according to an internal method.
- GLP compliance:
- no
- Specific details on test material used for the study:
- TEST MATERIAL
- name as cited in test report: p-diisopropylbenzene
- Molecular weight: 162 g/mol
- Molecular formula: C12H18
- Physical state: liquid
- Boiling point: 208 °C at 760 mmHg
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: not specified
- Stability with H+; OH-; Heat, Light, H2: given - Species:
- guinea pig
- Strain:
- not specified
- Type of coverage:
- occlusive
- Preparation of test site:
- other: depilated
- Vehicle:
- unchanged (no vehicle)
- Controls:
- no
- Amount / concentration applied:
- single dose
- Duration of treatment / exposure:
- 24 hours
- Observation period:
- 2 weeks
- Details on study design:
- occluded, single exposure, 24 hours
(guinea pig abdomen)
and
open, Repeated (10 doses) - 5 animals - Irritation parameter:
- overall irritation score
- Basis:
- animal:
- Remarks on result:
- other: Moderate erythema, edema and some necrosis.
- Irritation parameter:
- edema score
- Basis:
- animal:
- Time point:
- 24/48/72 h
- Remarks on result:
- not measured/tested
- Irritation parameter:
- erythema score
- Basis:
- animal:
- Time point:
- 24/48/72 h
- Remarks on result:
- not measured/tested
- Irritant / corrosive response data:
- The compound was a moderate skin irritant when applied to the depilated guinea pig abdomen under an occlusive wrap for 24 hours. It produced moderate erythema, edema and some necrosis. Thin eschars at one week, light scarring desquamation and alopecia at 2 weeks.
- Interpretation of results:
- Category 2 (irritant) based on GHS criteria
- Conclusions:
- p-diisopropylbenzene was rated a moderate irritant under the conditions of this study.
- Executive summary:
p-diisopropylbenzene was a moderate skin irritant when applied to the depilated guinea pig abdomen under an occlusive wrap for 24 hours.
It produced moderate erythema, edema and some necrosis. Thin eschars at one week, light scarring desquamation and alopecia at 2 weeks.
Occluded, single dose:
The compound produced moderate to severe erythema and edema and some necrosis initially; eschars were present after one week, and scarring, desquamation and alopecia were present after two weeks at doses ranging from 20 mL/g down to 1 mL/kg.
Open, Reapead (10 Doses) - 5 animals:
Moderate to severe erythema and edema replaced by thick, broken eschars at day 10.
Skin Absorption possible
Repeated daily application (10) of 0.5 mL of the material moderately exacerbated the initial response. Moderate to severe erythema and edema and petechial hemorrhages were present at day 1. By day 10, the application site in all animals was characterized by thick, broken eschars. Absorption of the compound through the skin was possible, since three of five animals in the repeated skin application test lost weight over the course of the study.
- Reason / purpose for cross-reference:
- reference to same study
Reference
- Endpoint:
- eye irritation: in vivo
- Remarks:
- in vivo study that was performed prior to current requirement for in vitro alternative testing
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26 January 1982 - 16 April 1984
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The eye irritation test was performed onto both eyes of 3 rabbits; in one eye of each rabbit, the material was immediately rinsed with water, while in the other eye, the material remained without washing.
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- TEST MATERIAL
- name as cited in test report: p-diisopropylbenzene
- Molecular weight: 162 g/mol
- Molecular formula: C12H18
- Physical state: liquid
- Boiling point: 208 °C at 760 mmHg
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: not specified
- Stability with H+; OH-; Heat, Light, H2: given - Species:
- rabbit
- Strain:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Controls:
- no
- Number of animals or in vitro replicates:
- 3animals
3 eyes washed, 3 eyes unwashed - Irritation parameter:
- overall irritation score
- Basis:
- animal: 1, 2, 3
- Time point:
- other: 1h
- Remarks on result:
- other: 3 of 3 animals with washing after treatment and 3 of 3 animals without washing after treatment showed slight irritation, limited to erythema of adnexa, resolved after one hour
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 1, 2, 3
- Time point:
- 24/48/72 h
- Score:
- 0
- Reversibility:
- other: not applicable
- Remarks on result:
- other: None of the three animals with washing after treatment and none of the three animals without washing after treatment showed Fluorescein stain on the cornea.
- Irritation parameter:
- conjunctivae score
- Basis:
- animal: 1, 2, 3
- Time point:
- 24/48/72 h
- Score:
- 0
- Reversibility:
- fully reversible
- Remarks on result:
- other: None of the three animals with washing after treatment and none of the three animals without washing after treatment showed Fluorescein stain on the adnexa. 1 hour after treatment the adnexa showed a slight erythema.
- Irritation parameter:
- iris score
- Basis:
- animal:
- Time point:
- 24/48/72 h
- Remarks on result:
- not measured/tested
- Irritation parameter:
- chemosis score
- Basis:
- animal:
- Time point:
- 24/48/72 h
- Score:
- 0
- Remarks on result:
- not measured/tested
- Irritant / corrosive response data:
- Irritation, limited to erythema of the adnexa, resolved after one hour. No adnexal or corneal staining was observed. Immediate washing was beneficial.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based upon the findings of this study, test item is slightly irritating to the eyes of rabbits. However, the criteria for classification and labelling according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No 1272/2008 are not met.
- Executive summary:
The eye irritation test was performed onto both eyes of 3 rabbits; in one eye of each rabbit, the material was immediately rinsed with water, while in the other eye, the material remained without washing. Immediately after instillation, slight erythema was observed that was limited to the adnexa, and washing was palliative. No adnexal or corneal staining was observed.
Based on the results observed in the present study, the criteria for classification and labelling according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No 1272/2008 are not met.
A very minor eye irritant.
The compound was a slight eye irritant when tested in six rabbit eyes (three washed and three unwashed). Irritation, limited to erythema of the adnexa, resolved after one hour. No adnexal or corneal staining was observed. Immediate washing was beneficial.
- Reason / purpose for cross-reference:
- reference to same study
Reference
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 26 January 1982 - 16 April 1984
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- GLP compliance:
- no
- Limit test:
- no
- Specific details on test material used for the study:
- TEST MATERIAL
- name as cited in test report: p-diisopropylbenzene
- Molecular weight: 162 g/mol
- Molecular formula: C12H18
- Physical state: liquid
- Boiling point: 198 °C at 760 mmHg
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: not specified
- Stability with H+; OH-; Heat, Light, H2: given - Species:
- rat
- Strain:
- not specified
- Sex:
- male
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- Rats were given a total of 11 treatments over a 15-day span
- Frequency of treatment:
- once daily
- Dose / conc.:
- 100 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- Groups of five male rats were gavaged with 1000 or 100 mg compound/kg/day for a total of eleven treatments over a 15 day span.
A control group of five animals were gavaged with distilled water at a dose of 1000 mg/kg/day. Weight gain and feed intake were comparable between groups. - Control animals:
- yes, concurrent vehicle
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- No abnormal clinical signs were observed with the exception of a single high-dose animal exhibited porphyrin nasal discharge, weight loss and possible aspiration pneumonia.
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- Weight gain and feed intake were comparable between groups.
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- several slight but statistically-significant differences were noted in the high-dose group, including increased platelets and monocytes. All other indices (red blood cell count, hemoglobin concentration, hematocrit, red cell indices, white blood cell counts and the remaining portions of the differential white blood cell count) were comparable to controls.
No alterations in hematology were noted in blood from the low dose group. - Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- A moderate decrease in serum glucose and a slight increase in creatinine in the high-dose animals; all other serum chemistry indices (alanine aminotransferase, aspartate aminotransferase, sorbitol dehydrogenase, alkaline phosphatase, and urea nitrogen) were comparable to controls.
No alterations in serum clinical chemistry were noted in blood from the low dose group. - Endocrine findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- No significant changes in absolute or relative kidney or spleen weights were noted.
There was a trend which implied a dose dependent increase in relative liver weights were observed in the high-dose group. - Gross pathological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Enlarged hearts were observed in 3 of 5 rats in the high-dose group, which was considered to have occurred as a result of general respiratory stress associated with extensive consolidation of the lung (hypertrophy or the hearts might have been triggered by the consolidation in the lung).
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- Even though the enlarged hearts had been observed in the gross pathological examination, no compound related effects were seen at histopathological examination.
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not examined
- Details on results:
- The liver may be a site of toxic action, and the no effect level (NOEL) may be in the range of 100 mg/kg.
- Key result
- Dose descriptor:
- NOEL
- Effect level:
- 100 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male
- Critical effects observed:
- no
- Conclusions:
- A daily dose of 100 mg/kg was considered to be a no effect level (NOEL).
- Executive summary:
The repeated dose toxicity test was done similar to OECD guideline 407. The test item was evaluated in a 2-week (subacute) oral toxicity study. Groups of five male rats were gavaged with 1000 or 100 mg compound/ kg/day for a total of eleven treatments over a 15 day span. A control group of five animals were gavaged with distilled water at a dose of 1000 mg/kg/day. The no effect level (NOEL) may be in the range of 100 mg/kg.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 984
- Report date:
- 1984
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- only 10 animals tested, not many details provided in the report
- Principles of method if other than guideline:
- only 10 animals tested, not many details provided in the report
- GLP compliance:
- not specified
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- in vivo study that was performed prior to current requirement for in vitro alternative testing
Test material
- Reference substance name:
- 1,4-diisopropylbenzene
- EC Number:
- 202-826-9
- EC Name:
- 1,4-diisopropylbenzene
- Cas Number:
- 100-18-5
- Molecular formula:
- C12H18
- IUPAC Name:
- 1,4-bis(propan-2-yl)benzene
Constituent 1
- Specific details on test material used for the study:
- TEST MATERIAL
- name as cited in test report: p-diisopropylbenzene
- Molecular weight: 162 g/mol
- Molecular formula: C12H18
- Physical state: liquid
- Boiling point: 208 °C at 760 mmHg
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: not specified
- Stability with H+; OH-; Heat, Light, H2: given
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- not specified
- Sex:
- not specified
Study design: in vivo (non-LLNA)
Induction
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100 % as received
Challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100 % as received
- Day(s)/duration:
- not specified
- No. of animals per dose:
- 10
- Details on study design:
- no details given
- Positive control substance(s):
- no
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- other: not specified
- Group:
- positive control
- Dose level:
- not specified
- Remarks on result:
- other: not specified
- Reading:
- other: not specified
- Group:
- negative control
- Dose level:
- not specified
- No. with + reactions:
- 0
- Remarks on result:
- other: not specified
- Reading:
- other: not specified
- Group:
- test chemical
- Dose level:
- not specified
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: not specified
Any other information on results incl. tables
The material did not elicit a positive response when administreed to ten guinea pigs in a standardized skin sensitization test.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based upon the results of this study, test item is not a dermal sensitizer in guinea pigs
- Executive summary:
A skin sensitisation test was performed on guinea pigs. The material did no elicit a positive response when administered to ten guinea pigs in a standardized skin sensitization test.
Consequently, estimated human risk is low and the test substance was determined to be non-sensitizing in guinea pigs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.